Selagintriflavonoids with BACE1 inhibitory activity from the fern Selaginella doederleinii
Related Experiment Video
Updated: Mar 11, 2026

A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources
Published on: January 27, 2026
Zhenxing Zou1, Pingsheng Xu2, Guogang Zhang2
1Xiangya Hospital of Central South University, Changsha, 410008, People's Republic of China; School of Pharmaceutical Sciences, Central South University, Changsha, 410013, People's Republic of China.
Abstract:
Eight triflavonoids, selagintriflavonoids A-H, were isolated from whole herbs of Selaginella doederleinii. The structures of compounds selagintriflavonoids A-C consisted of three naringenin units, whereas those of selagintriflavonoids D-H consisted of apigenin and two naringenin moieties. The structures and absolute configurations of the compounds were determined based on NMR, HRESIMS, and experimental and calculated electronic circular dichroism (ECD) data. The ability of the compounds to inhibit β-secretase (BACE1) was also evaluated. All compounds exhibited BACE1 inhibition with IC50 values ranging from 0.75 to 46.99 μM. Selagintriflavonoid A exhibited the strongest inhibition (0.75 μM) and is thus a promising compound for treating Alzheimer's disease.

